HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
GUOQUAN (02517) spent HKD 1.1729 million to buy back 643,200 shares on January 20th.
20/01/2025
GMT Eight
GUOQUAN (02517) announced that it will spend HKD 1.1729 million to repurchase 643,200 shares on January 20, 2025.
Shanghai Fosun Pharmaceutical subsidiary Oxazepam tablets received drug registration approval.
Tianshan Aluminum Group (002532.SZ) forecasts a net profit of 4.45 billion yuan for the full year 2024, a year-on-year increase of 101.79%.
RECOMMEND
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 2%, hitting a new all-time high.
22/01/2025
US Stock Market Move | Q4 earnings per share exceeded expectations, Anheuser-Busch InBev (APH.US) rose over 6%, reaching a new all-time high.
22/01/2025
US Stock Market Move | AI concept stocks perform strongly, Arm Holdings (ARM.US) rises more than 14%.
22/01/2025
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com